Fig. 7.
Fig. 7. Intracellular localization of VE-cadherin in VECD-1–treated ECs. / (A-F) The addition of 20 μg/mL VECD-1 disrupted EC-EC contact, thereby allowing ECs to scatter. VE-cadherin was translocated from cell surfaces to the intracellular cytoplasm (panel E, arrow). Internalized VE-cadherin colocalized with γ-catenin (panel A, arrow) (γ-catenin–VE-cadherin [VECD-1]; panels A-B). (D-F) In contrast, ZO1 remains at the cell-cell junctions (ZO1–secondary Ab; panels D-E). Panels C and F are merged images. Scale bar, 20 μm.

Intracellular localization of VE-cadherin in VECD-1–treated ECs.

(A-F) The addition of 20 μg/mL VECD-1 disrupted EC-EC contact, thereby allowing ECs to scatter. VE-cadherin was translocated from cell surfaces to the intracellular cytoplasm (panel E, arrow). Internalized VE-cadherin colocalized with γ-catenin (panel A, arrow) (γ-catenin–VE-cadherin [VECD-1]; panels A-B). (D-F) In contrast, ZO1 remains at the cell-cell junctions (ZO1–secondary Ab; panels D-E). Panels C and F are merged images. Scale bar, 20 μm.

Close Modal

or Create an Account

Close Modal
Close Modal